U

Universe Pharmaceuticals Inc
NASDAQ:UPC

Watchlist Manager
Universe Pharmaceuticals Inc
NASDAQ:UPC
Watchlist
Price: 4.067 USD -4.87% Market Closed
Market Cap: $2.3m

Net Margin

5.6%
Current
Improving
by 36.9%
vs 3-y average of -31.2%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
5.6%
=
Net Income
$1.1m
/
Revenue
$19.3m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
5.6%
=
Net Income
$1.1m
/
Revenue
$19.3m

Peer Comparison

Country Company Market Cap Net
Margin
CN
Universe Pharmaceuticals Inc
NASDAQ:UPC
2.3m USD
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
F:1PK
5.1B EUR
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
CH
Novartis AG
SIX:NOVN
221.9B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
267.9B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.6B USD
Loading...

Market Distribution

In line with most companies in China
Percentile
59th
Based on 8 721 companies
59th percentile
5.6%
Low
-416 945.9% — -1.5%
Typical Range
-1.5% — 8.9%
High
8.9% — 17 382.1%
Distribution Statistics
China
Min -416 945.9%
30th Percentile -1.5%
Median 3.5%
70th Percentile 8.9%
Max 17 382.1%

Universe Pharmaceuticals Inc
Glance View

Market Cap
2.3m USD
Industry
Pharmaceuticals

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The company is headquartered in Ji'An, Jiangxi and currently employs 263 full-time employees. The company went IPO on 2021-03-23. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The firm mainly conducts its businesses within the Chinese market.

UPC Intrinsic Value
35.921 USD
Undervaluation 89%
Intrinsic Value
Price
U
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
5.6%
=
Net Income
$1.1m
/
Revenue
$19.3m
What is Universe Pharmaceuticals Inc's current Net Margin?

The current Net Margin for Universe Pharmaceuticals Inc is 5.6%, which is above its 3-year median of -31.2%.

How has Net Margin changed over time?

Over the last 3 years, Universe Pharmaceuticals Inc’s Net Margin has decreased from 18.1% to 5.6%. During this period, it reached a low of -71% on Mar 31, 2024 and a high of 18.1% on Mar 31, 2022.

Back to Top